SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-046171
Filing Date
2011-08-12
Accepted
2011-08-12 16:49:06
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v228989_10q.htm 10-Q 912778
2 EXHIBIT 31.1 v228989_ex31-1.htm EX-31.1 15192
3 EXHIBIT 31.2 v228989_ex31-2.htm EX-31.2 15225
4 EXHIBIT 32.1 v228989_ex32-1.htm EX-32.1 9493
  Complete submission text file 0001144204-11-046171.txt   2809391

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nvlt-20110630.xml EX-101.INS 329085
6 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20110630.xsd EX-101.SCH 14068
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20110630_cal.xml EX-101.CAL 39117
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20110630_def.xml EX-101.DEF 88645
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20110630_lab.xml EX-101.LAB 89479
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20110630_pre.xml EX-101.PRE 96453
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 111031969
SIC: 2834 Pharmaceutical Preparations